Effects of Aging on the Human Nervous System

  • J. C. de la Torre
  • L. A. Fay


Elderly patients are known to represent a major proportion of problems affecting the central nervous system (CNS) and consequently make up a significant percentage of patients requiring elective or emergency surgery of the brain and spinal cord. The significance of this statistic is of great medical and socioeconomic importance.


Cerebral Blood Flow Normal Aging Aging Brain Compute Tomography Cereb Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lipowski ZJ. Delirium and impaired consciousness. In: Evans JG, Williams TF (eds) Oxford Textbook of Geriatric Medicine. Oxford: Oxford University Press, 1992:490–495.Google Scholar
  2. 2.
    Maletta GJ, Pirozzolo FJ. Introduction to the aging nervous system. In: Maletta GJ, Pirozzolo FJ (eds) The Aging Nervous System. New York: Praeger, 1980:3–9.Google Scholar
  3. 3.
    Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging 1993;14:623–627.PubMedGoogle Scholar
  4. 4.
    Peters G, Vaughan DW. Central nervous system. In: Johnson JF (ed) Aging and Cell Structure, vol 1. New York: Plenum, 1981:1–34.Google Scholar
  5. 5.
    Blessed G, Tomlinson BE, Roth M. The association between quantiative measures of dementia and of senile change. Br J Psychiatry 1968;114:797.PubMedGoogle Scholar
  6. 6.
    Duckett S. The normal aging human brain. In: Duckett S (ed) The Pathology of the Aging Human Nervous System. Philadelphia: Lea & Febiger, 1991.Google Scholar
  7. 7.
    Hoch-Ligeti C. Effect of aging on the central nervous system. J Am Geriatr Soc 1963;2:403.Google Scholar
  8. 8.
    Petit TL. Synaptic plasticity and the structural basis of learning and memory. In: Petit TL, Ivy GO (eds) Neural Plasticity: A Lifespan Approach, vol 36. New York: Liss, 1988:201–234.Google Scholar
  9. 9.
    Damon A. Discrepancies between findings of longitudinal and cross-sectional studies in adult life: physique and physiology. Hum Dev 1965;8:16–22.PubMedGoogle Scholar
  10. 10.
    Katzman R. Human nervous system. In: Masoro EJ (ed) Handbook of Physiology, Sect 11: Aging. New York: Oxford University Press, 1995:325–344.Google Scholar
  11. 11.
    Baron JC, Marchai G. Vieillessement cérébral et cardio vasculare et metabolisme énergétique, cérébral. Paris: Presse Med 1992;21:1231–1237.Google Scholar
  12. 12.
    Baron JC, Rougemont D, Soussaline F. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab 1984;4:140–149.PubMedGoogle Scholar
  13. 13.
    de la Torre JC. Cerebrovascular changes in the aging brain. Adv Cell Aging Gerontol 1997;2:77–107.Google Scholar
  14. 14.
    Lassen NA, Feinberg I, Lane MH. Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia. J Clin Invest 1960;39:491.PubMedGoogle Scholar
  15. 15.
    Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly. Cerebrovasc Brain Metab Rev 1993;5:122–146.PubMedGoogle Scholar
  16. 16.
    Pantano P, Baron JC, Lebrum-Grandie P, Duguesnoy N, Boussen M, Comar G. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1984; 15: 635–641.PubMedGoogle Scholar
  17. 17.
    de la Torre JC. Impaired brain microcirculation may trigger Alzheimer’s disease. Neurosci Behav Rev 1994;18:397–401.Google Scholar
  18. 18.
    Brizzee KR, Ordy JM, Knox C, Jirge SK. Morphology and aging in the brain. In: Maletta GJ, Pirozzolo FJ (eds) The Aging Nervous System. New York: Praeger, 1980:10–18.Google Scholar
  19. 19.
    Glees P, Hasan M. Lipofuscin. In: Neuronal Aging and Disease. Stuttgart: Thieme, 1976.Google Scholar
  20. 20.
    Ranson SW. The Anatomy of the Nervous System, 8th ed, revised by Clark SL. Philadelphia: Saunders, 1951.Google Scholar
  21. 21.
    Schlote W, Boellaard JW. Role of lipopigment during aging of nerve and glial cells in the human central nervous system. In: Cervos-Navarro J, Sarkander HI (eds) Brain Aging: Neuropathology and Neuropharmacology, New York: Raven, 1983:27–28.Google Scholar
  22. 22.
    Brizzee KR, Sherwood N, Timiras PS. A comparison of various depth levels: cerebral cortex of young adults and aged Long-Evans rats. J Gerontol 1968;23:289–297.PubMedGoogle Scholar
  23. 23.
    Brunetti M, Miscena A, Salviati A, Gaiti A. Effect of aging on the rate of axonal transport of choline phosphoglycerides. Neurochem Res 1987;12:61–65.PubMedGoogle Scholar
  24. 24.
    Inestrosa NC, Alvarez J. Axons grow in the aging rat but fast transport and acetylcholinesterase content remain unchanged. Brain Res 1988;441:331–338.PubMedGoogle Scholar
  25. 25.
    Anderton BH, Brion JP, Flament Durand J, et al. Changes in the neuronal cytoskeleton in aging and disease. In: Bergener M, Ermini M, Stahelin HB (eds) Dimensions in Aging. San Diego: Academic, 1986:69–90.Google Scholar
  26. 26.
    Ferrell BR, Ferrell BA, Kaiko R. Pain in the elderly. Presented at the American Pain Society, St. Louis, October 1990.Google Scholar
  27. 27.
    Peters A, Rosene D. The effects of aging on area 46 of the frontal cortex of the rhesus monkey. Cereb Cortex 1994;6:621–628.Google Scholar
  28. 28.
    Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB. Progressive changes in aging human cortex. Exp Neurol 1975;47:392–403.PubMedGoogle Scholar
  29. 29.
    Diamond MC, Connor JR. Morphological measurements in the aging rat cerebral cortex. In: Scheff SW (ed) Aging and Recovery of Function in the Central Nervous System. New York: Plenum, 1984:47–55.Google Scholar
  30. 30.
    Rogers RL, Meyer JS, Mortel KF. After reaching retirement age, physical activity sustains cerebral perfusion and cognition. J Am Geriatr Soc 1990;38:123–128.PubMedGoogle Scholar
  31. 31.
    Kristersson R. Retrograde transport of macromoelcules in axons. Annu Rev Pharmacol Toxicol 1987;18:97–110.Google Scholar
  32. 32.
    Kandel ER, Schwartz JH. Directly gated transmission at central synapses. In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of Neural Science, 3rd ed. East Norwalk, CT: McGraw-Hill, 1991:153–172.Google Scholar
  33. 33.
    Vale RD, Schnapp BJ, Reese TS, Sheetz MP. Movement of organelles along filaments dissociated from the axoplasm of the squid giant axon. Cell 1985;40:559–569.PubMedGoogle Scholar
  34. 34.
    Viancour TA, Kreiter NA. Vesicular fast axonal transport in young and old rat axons. Brain Res 1993;628:209–217.PubMedGoogle Scholar
  35. 35.
    Edmonds B, Koenig E. Powering of bulk transport (varicosities) and differential sensitivities of directional transport in growing axons. Brain Res 1987;406:288–293.PubMedGoogle Scholar
  36. 36.
    Stromska DP, Ochs S. Axoplasmic transport in aged rats. Exp Neurol 1982;77:215–224.PubMedGoogle Scholar
  37. 37.
    Strehler BL, Barrows CH. Senescence: cell biological aspects of aging. In: Schjjeide OA, DeVellis J (eds) Cell Differentiation. New York: Van Nostrand Reinhold, 1970.Google Scholar
  38. 38.
    McMartin D, O’Connor JA Jr. Effect of age on axoplasmic transport of Cholinesterase in rat sciatic nerves. Mech Ageing Dev 1979;10:241–248.PubMedGoogle Scholar
  39. 39.
    Certoni-Freddari C, Fattoretti P, Paoloni R, Caselli U, Galeazzi L, Meier-Ruge W. Synaptic structural dynamics and aging. In: Meier-Ruge W (ed) Gerontology. New York: Karger, 1996:170–180.Google Scholar
  40. 40.
    deToledo-Morrell L, Geinisman Y, Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: relation to memory disorders. Neurobiol Aging 1988;9: 581–590.PubMedGoogle Scholar
  41. 41.
    Meier-Ruge W. Morphometric methods and their potential value for gerontological research. In: von Hahn HP (ed) Interdisciplinary Topics: Gerontology. Basel: Karger, 1988:90–100.Google Scholar
  42. 42.
    Dyson SE, Jones DG. Synaptic remodelling during development and maturation: junction differentiation and splitting as a mechanism for modifying connectivity. Dev Brain Res 1984;13:125–137.Google Scholar
  43. 43.
    Bertoni-Freddari C, Fattoretti P, Casoli T, Meier-Ruge W, Ulrich J. Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer’s disease. Brain Res 1990;517:69–75.PubMedGoogle Scholar
  44. 44.
    Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer’s disease. Neurobiol Aging 1990;11:29–37.PubMedGoogle Scholar
  45. 45.
    Scheff SW, Scott SA, DeKosky ST. Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats. Neurobiol Aging 1991;12:3–12.PubMedGoogle Scholar
  46. 46.
    Desmond NL, Levy WB. Changes in the numerical density of synaptic contacts with long-term potentiation in the hippocampal dentate gyrus. J Comp Neurol 1986;253:466–475.PubMedGoogle Scholar
  47. 47.
    Carlin RK, Siekevitz P. Plasticity in the central nervous system: do synapses divide? Proc Natl Acad Sci USA 1983;80:3517–3521.PubMedGoogle Scholar
  48. 48.
    Nieto-Sampedro M, Hoff SF, Cotman CW. Perforated postsynaptic densities: probable intermediates in synapse turnover. Proc Natl Acad Sci USA 1982;79:5718–5722.PubMedGoogle Scholar
  49. 49.
    Geinisman Y, Morrell F, de Toledo-Morrell L. Axospinous synapses with segmented postsynaptic densities: a morphologically distinct synaptic subtype contributing to the number of profiles of perforated synapses visualized in random sections. Brain Res 1987;423:179–188.PubMedGoogle Scholar
  50. 50.
    Wolff JR, Laskawi R, Spatz WB, Missler M. Structural dynamics of synapses and synaptic components. Behav Brain Res 1995;66:13–20.PubMedGoogle Scholar
  51. 51.
    Wakita H, Tomimoto H, Kimura J. Glial activation and white matter changes in rat brain induced by chronic cerebral hypoperfusion. Acta Neuropathol (Berlin) 1994; 87:484–492.Google Scholar
  52. 52.
    Exton-Smith AN, Collins KJ. The autonomic nervous system. In: Pathy MSJ (ed) Principles and Practice of Geriatric Medicine, 2nd ed. New York: Wiley, 1997:817–820.Google Scholar
  53. 53.
    Frolkis W, Bezrukov VV, Duplenko YP, Shcheglovea IV, Shevtchnk VG, Verkhratsky NS. Acetylcholine metabolism and cholinergic regulation of functions in aging, Gerontologia 1973;19:45–54.PubMedGoogle Scholar
  54. 54.
    Smith CUM. Elements of Molecular Neurobiology, 2nd ed. New York: Wiley, 1996:335–338.Google Scholar
  55. 55.
    de la Torre JC. Dynamics of Brain Monoamines. New York: Plenum, 1972.Google Scholar
  56. 56.
    Nakazawa K, Koizumi S, Inoue D. ATP as a neurotransmitter in the brain: its possibility based upon recent findings. Nohon Shinkei Seishin Yakurigaky Zasshi 1995;15(1):1–11.Google Scholar
  57. 57.
    Strosznajder J, Strosznajder RP. ATP, a potent regulator of inositol phospholipids-phospholipase C and lipid mediators in brain cortex. Acta Neurobiol Exp 1996;56:527–534.Google Scholar
  58. 58.
    Todorov LD, Mihaylova TS, Westfall TD, et al. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 1997;387:76–79.PubMedGoogle Scholar
  59. 59.
    Gazzaley AH. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc Natl Acad Sci USA 1996;93: 3121–3123.PubMedGoogle Scholar
  60. 60.
    Severson JA. Synaptic regulation of neurotransmitter function in aging. In: Rothstein M (ed) Review of Biological Research in Aging, vol 3. New York: Liss, 1987:191–206.Google Scholar
  61. 61.
    Bertel O, Buhler FR, Kiowski W, Lutold BE. Decreased beta adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980;2:130–138.PubMedGoogle Scholar
  62. 62.
    Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoreceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:181–186.PubMedGoogle Scholar
  63. 63.
    Buhler FR, Burkart F, Lutold BE, Kung M, Marbet G, Pfisterer M. Antihypertensive beta-blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol 1975;36:653–669.PubMedGoogle Scholar
  64. 64.
    Joseph JA, Bartus RT, Clody D, et al. Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor upregulation. Neurobiol Aging 1983;4:313–319.PubMedGoogle Scholar
  65. 65.
    Roberts J, Turner N. Age-related changes in autonomic function of catecholamines. In: Rothstein M (ed) Review of Biological Research in Aging, vol 3. New York: Liss, 1987:257–298.Google Scholar
  66. 66.
    Youdin MBH, Riederer P. Understanding Parkinson’s disease. Sci Am 1997;276:52–59.Google Scholar
  67. 67.
    Marcusson JO, Oreland L, Winblad B. Effect of age on human brain serotonin, (S-l) binding sites. J Neurochem 1984;43:1699–1705.PubMedGoogle Scholar
  68. 68.
    Allen SJ, Benton JS, Goodhardt MJ, et al. Biochemical evidence of selective nerve cell changes in the normal aging human and rat brain. J Neurochem 1983;41: 256–265.PubMedGoogle Scholar
  69. 69.
    DeBlasi A, Cotecchia S, Tiziana M. Selective changes of receptor binding in brain regions of aged rats. Life Sci 1982;31:335–340.Google Scholar
  70. 70.
    Mann DM, Yates PO, Stamp JE. The relationship between lipofuscin pigment in aging in the human nervous system. J Neurol Sci 1978;37:83–93.PubMedGoogle Scholar
  71. 71.
    Bjorkerud S. Isolated lipofuscin granules: a survey of a new field. Adv Gerontol Res 1964;1:257–288.Google Scholar
  72. 72.
    Porta EA, Mower HF, Lee C, Palimbo NE. Differential features between lipofuscin (age pigment) and various experimentally produced “ceroid pigments.” In: Lipofuscin— 1987: State of the Art. Amsterdam: Excepta Medica, 1988:341–374.Google Scholar
  73. 73.
    D’Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH. Evidence for neuromelanin in MPTP-induced neurotoxicity. Nature 1987;327:324–326.PubMedGoogle Scholar
  74. 74.
    Kopin IJ. Features of the dopaminergic neurotoxin MPTP. Ann NY Acad Sci 1992;648:96–104.PubMedGoogle Scholar
  75. 75.
    Zeman W, Donohue S, Dyken P, Green J. The neuronal ceroid lipofuscinoses (Batten-Vogt syndrome). In: Vinken P, Bruyn GW (eds) Handbook of Clinical Neurology, vol 10. Amsterdam: North Holland, 1970:588–679.Google Scholar
  76. 76.
    Stadtman ER. Protein oxidation and aging. Science 1992;257:1220–1224.PubMedGoogle Scholar
  77. 77.
    Brody H. An examination of cerebral cortex and brainstem in aging. In: Terry RD, Gersham S (eds) Neurobiology of Aging. New York: Raven, 1976:177–181.Google Scholar
  78. 78.
    Terry RD, De Teresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 1987;21: 530–539.PubMedGoogle Scholar
  79. 79.
    Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease. Neurobiol Aging 1987;8:521–545.PubMedGoogle Scholar
  80. 80.
    Finch CE. Neuron atrophy during aging: programmed or sporadic? TINS 1993;16:104–110.PubMedGoogle Scholar
  81. 81.
    Finch CE. Longevity, Senescence and the Genome. Chicago: University of Chicago Press, 1990:188–193.Google Scholar
  82. 82.
    Haug H. The evaluation of cell-densities and of nerve-cell-size distribution by stereological procedures in a layered tissue (cortex cerebri). Microsc Acta 1979;82:147–161.PubMedGoogle Scholar
  83. 83.
    Haug H, Barmwater U, Eggers R, Fischer D, Kuhl S, Sass NL. Anatomical changes in aging brain: morphometric analysis of the human prosencephalon. In: Cervos-Navarro J, Sarkander HI (eds) Brain Aging: Neuropathology and Neuropharmacology. New York: Raven, 1983:1–12.Google Scholar
  84. 84.
    Haug H. Macroscopic and microscopic morphometry of the human brain and cortex: a survey in the light of new results. Brain Pathol 1984;1:123–149.Google Scholar
  85. 85.
    Terry RD. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981;10:184.PubMedGoogle Scholar
  86. 86.
    de la Torre JC, Cada A, Nelson N, Davis G, Sutherland RJ, Gonzalez Lima F. Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neurosci Lett 1997;223:165–168.PubMedGoogle Scholar
  87. 87.
    Haug H. Nervous tissue. In: Weibel ER (ed) Stereological Methods, vol 1: Practical Methods for Biological Morphometry, London: Academic, 1979:311–322.Google Scholar
  88. 88.
    Morrison JH, Huf PR. Life and death of neurons in the aging brain. Science 1997;278:412–419.PubMedGoogle Scholar
  89. 89.
    Sofroniew MV, Isacson O, Bjorklund A. Corticol grafts prevent atrophy of cholinergic basal nucleus neurons induced by excitotoxic cortical damage. Brain Res 1986;378:409–415.PubMedGoogle Scholar
  90. 90.
    de la Torre JC, Fortin T, Park G, Pappas B, Saunders J, Richard M. Brain blood-flow restoration “rescues” chronically damaged rat CA1 neurons. Brain Res 1993;623:6–15.PubMedGoogle Scholar
  91. 91.
    Murphy DG, Decarli C, Schapiro MB, Rapoport SE, Horwitz B. Age-related differences in volumes of subcortical nuclei, brain matter and cerebral spinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992;49:839–845.PubMedGoogle Scholar
  92. 92.
    Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. Am J Radiol 1994;162:1267–1278.Google Scholar
  93. 93.
    Flood DG, Coleman PD. Neuron numbers and sizes in aging brain: comparisons of human, monkey and rodent data. Neurobiol Aging 1988;94:453–463.Google Scholar
  94. 94.
    Mervis R. Cytomorphological alterations in the aging animal brain with emphasis on Golgi studies. In: Johnson JE (ed) Aging and Cell Structure. New York: Plenum, 1981:143–186.Google Scholar
  95. 95.
    Meier-Ruge W, Hunziker O, Iwangoff P, Reichmeier K, Sandoz P. Alterations of morphological and neurochemical parameters of the brain due to normal aging. In: Nandy K (ed) Senile Dementia: A Biological Approach. Amsterdam: Elsevier North-Holland, 1987:33–44.Google Scholar
  96. 96.
    Flood DG, Coleman PD. Hippocampal plasticity in normal aging and decreased plasticity in Alzheimer’s disease. Prog Brain Res 1990;83:435–443.PubMedGoogle Scholar
  97. 97.
    Kemper T. Neuroanatomical and neuropathological changes in normal aging and in dementia. In: Albert ML (ed) Clinical Neurology of Aging. New York: Oxford University Press, 1984:9–52.Google Scholar
  98. 98.
    Duara R, London ED, Rapoport SI. Changes in structure and energy metabolism of the aging brain. In: Finch CE, Schneider EL (eds) Handbook of the Biology of Aging. New York: Van Nostrand Reinhold, 1985:595–616.Google Scholar
  99. 99.
    Kety SS. Human cerebral blood flow and oxygen consumption as related to aging. In: Moore JE, Merritt HH, Masselink RJ (eds) The Neurologic and Psychiatric Aspects of the Disorders of Aging. Baltimore: Williams & Wilkins, 1955:31–45.Google Scholar
  100. 100.
    Dastur DK. Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J Cereb Blood Flow Metab 1985;5:1–9.PubMedGoogle Scholar
  101. 101.
    Fazekas JF, Alivan RW, Bessman AN. Cerebral physiology of the aged. Am J Med Sci 1952:223–245.Google Scholar
  102. 102.
    Scheinberg P, Blackburn I, Rich M. Effects of aging on cerebral circulation and metabolism. Arch Neurol Psychiatry 1953;70:77.Google Scholar
  103. 103.
    Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 1985;63:29.PubMedGoogle Scholar
  104. 104.
    Hossmann KA. Post-ischemic resuscitation of the brain: selective vulnerability versus global resistance. Prog Brain Res 1985;63:3.PubMedGoogle Scholar
  105. 105.
    Tymianski M, Sattler RG. Is calcium involved in excitotoxic or ischemic neuronal damage? In: Welch KMA, Caplan L, Reis DJ, Siesjo BK, Weir B (eds) Primer on Cerebrovascular Diseases. San Diego: Academic, 1997:190–198.Google Scholar
  106. 106.
    Greenmayre JT. The role of glutamate in neurotransmission and in neurologic disease. Arch Neurol 1986;43:1058.Google Scholar
  107. 107.
    Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1988;45:148.Google Scholar
  108. 108.
    Vinters HV. Vascular diseases in the elderly. In: Duckett S, de la Torre J (eds). Pathology of the Aging Human Nervous System. 2nd ed. New York: Oxford University Press, 2000: in press.Google Scholar
  109. 109.
    Grady CL, Horwitz B, Schapiro MB, Rapoport SI. Changes in the integrated activity of the brain with healthy aging and dementia of the Alzheimer type. In: Rapoport SI, Petit H, Leys D, Christe Y (eds) Aging Brain and Dementia: New Trends in Diagnosis and Therapy. New York: Liss, 1990:355–369.Google Scholar
  110. 110.
    Leenders KL, Perani D, Lammertsma AA. Cerebral blood flow, blood volume and oxygen utilization; normal values and effect of age. Brain 1990;113:27–47.PubMedGoogle Scholar
  111. 111.
    Lenzi GL, Frackowiak RSJ, Jones T. CMRO2 and CBF by oxygen-15 inhalation technique. Eur Neurol 1981;20:285–290.PubMedGoogle Scholar
  112. 112.
    Marchai G, Rioux P, Petit-Taboue MC. The effects of optimally healthy aging on cerebral oxygen metabolism, blood flow and blood volume in humans: a PET study. J Cereb Blood How Metab 1991;ll(suppl 2):S785.Google Scholar
  113. 113.
    Yamaguchi T, Kanno I, Uemura K. Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke 1986;17:1220–1228.PubMedGoogle Scholar
  114. 114.
    Itoh M, Hatazawa J, Miyazawa H. Stability of cerebral blood flow and oxygen metabolism during normal aging. Gerontology 1990;36:43–48.PubMedGoogle Scholar
  115. 115.
    Frackowiak RSJ, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980;4:727–736.PubMedGoogle Scholar
  116. 116.
    Frackowiak RSJ, Pozzilli C, Legg NJ. Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753–778.PubMedGoogle Scholar
  117. 117.
    Shirakura T, Kubota K, Tamura K. Blood viscosity and cerebral blood flow in the aged. Jpn J Geriatr 1993;30:174–181.Google Scholar
  118. 118.
    Grady C. Quantitative comparison of measurements of cerebral glucose rate made with two positron cameras. J Cereb Blood Flow Metab 1991;11:A57-A63.PubMedGoogle Scholar
  119. 119.
    Pawlik G, Heiss WD, Beil C, Wienhard K, Herholtz K, Wagner K. PET demonstrates differential age dependence, asymmetry and response to various stimuli of regional brain glucose metabolism in healthy volunteers. J Cereb Blood How Metab 1987;7(suppl 1):S376.Google Scholar
  120. 120.
    de Leon M, George AE, Tomanelli J. Positron emission tomography studies of normal aging: a replication of PET III and 18F FDG using PET VI and 11-CDG. Neurobiol Aging 1987;8:319–323.PubMedGoogle Scholar
  121. 121.
    Duara R, Grady C, Haxby J. Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 1984;16:702–713.Google Scholar
  122. 122.
    Junck L, Moen JG, Bluemlein I. Cerebral glucose metabolism in normal aging studied with PET. J Cereb Blood Metab 1989;9(suppl 1):S524.Google Scholar
  123. 123.
    Kalaria RN, Harik SI. Reduced glucose transporter at the blood-brain barrier and cerebral cortex in Alzheimer’s disease. J Neurochem 1989;53:1083–1088.PubMedGoogle Scholar
  124. 124.
    Stewart RR, Morrazzi CA. Oxygen transport in the human brain: analytical solutions. Adv Exp Med Biol 1973;37: 843–848.PubMedGoogle Scholar
  125. 125.
    Alavi A. Regional cerebral glucose metabolism. Exp Brain Res 1982;5(suppl 5):187–195.PubMedGoogle Scholar
  126. 126.
    Kuhl DE. Effects of human aging on patterns of local cerebral glucose utilization determined by the 18F fluorodeoxyglucose method. J Cereb Blood Flow Metabol 1982;2:163.Google Scholar
  127. 127.
    Kenshalo DR. Somesthetic sensitivity in young and elderly humans. J Gerontol 1986;41:732.PubMedGoogle Scholar
  128. 128.
    Meier-Ruge W (ed). The Elderly Patient in General Practice. New York: Karger, 1987:78.Google Scholar
  129. 129.
    Verrillo RT. Age related changes in the sensitivity to vibration. J Gerontol 1980;35:185–193.PubMedGoogle Scholar
  130. 130.
    Verrillo RT, Verrillo V. Sensory and perceptual performance. In: Charness N (ed) Aging and Human Performance. New York: Wiley, 1985:1.Google Scholar
  131. 131.
    Marshall J, Grindle J, Ansell PL, Brewein B. Convolution in human rods: an aging process. Br J Opthalmol 1979;63:181–187.Google Scholar
  132. 132.
    Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer’s disease and aging. Ann Neurol 1993;33:248–257.PubMedGoogle Scholar
  133. 133.
    Gao H, Hollyfield JG. Aging of the human retina differential loss of neurons and retinal pigment epithelial cells. Invest Opthalmol Vis Sci 1992;33:1–17.Google Scholar
  134. 134.
    Skinner HB, Barrack RL, Cook SD. Age-related declines in proprioception. Clin Orthop 1984;184:208.PubMedGoogle Scholar
  135. 135.
    Pickles JO. Sensorineural hearing loss. In: An Introduction to the Physiology of Hearing, 2nd ed. San Diego: Academic, 1988:310–311.Google Scholar
  136. 136.
    Wall PD, Noordenbos W. Sensory functions which remain in man after complete transection of dorsal columns. Brain 1977;100:641–653.PubMedGoogle Scholar
  137. 137.
    Drewnoswki A, Henderson SA, Driscoll A, Rolls BJ. Salt taste perceptions and preferences are unrelated to sodium consumption in healthy older adults. J Am Diet Assoc 1996;96:471–474.Google Scholar
  138. 138.
    Schiffman SS, Lindley MS, Clark TB, Makino C. Molecular mechanism of sweet taste: relationship of hydrogen bonding to taste sensitivity for both young and elderly. Neurobiol Aging 1981;2:173–185.PubMedGoogle Scholar
  139. 139.
    Murphy C, Gilmore MM. Quality specific effects of aging on the human taste system. J Percept Psychophys 1989;45:121–128.Google Scholar
  140. 140.
    Bartoshuk LM. Taste, robust across the age span? Ann NY Acad Sci 1989;561:65–75.PubMedGoogle Scholar
  141. 141.
    Cain WS, Stevens JC. Uniformity of olfactory loss in aging. Ann NY Acad Sci 1989;561:29–38.PubMedGoogle Scholar
  142. 142.
    Doty RL. Influence of age and age related diseases on olfactory function. Ann NY Acad Sci 1989;561:76–86.PubMedGoogle Scholar
  143. 143.
    Broe GA, Williamson M, Tate PL, Locke M, McFarlane A, Mitchell R. Senescent gait disorder and forgetfulness? Normal ageing or early dementia. In: Fenelon B, Pfister HP (eds) Proceedings of the 1983 Brain Impairment Conference and Workshops. Victoria: Australian Society for the Study of Brain Impairment, 1983:269–277.Google Scholar
  144. 144.
    Paige GD. The aging vestibulo-ocular reflex (VOR) and adaptive plasticity. Acta Otolaryngol Suppl (Stockh) 1991;481:297.Google Scholar
  145. 145.
    Koller WC, Glatt SL, Fox JH. Senile gait: a distinct neurologic entity. Clin Geriatr Med 1985;1:661–668.PubMedGoogle Scholar
  146. 146.
    Scheibel AB. Falls, motor dysfunction, and correlative neurohistologic changes. Clin Geriatr Med 1985;1:671.PubMedGoogle Scholar
  147. 147.
    Drachman DA, Zaks MS. The memory cliff beyond span in immediate recall. Psychol Rep 1967;21:105–112.PubMedGoogle Scholar
  148. 148.
    Baddeley AD, Hitch GJ. Working memory. In: Bower G (ed) Recent Advances in Learning and Motivation. San Diego: Academic, 1974:47–90.Google Scholar
  149. 149.
    Craik FIM. Age differences in human memory. In: Birren JE, Schaie KW (eds) Handbook of the Psychology of Aging. New York: Van Nostrand Rheinhold, 1977.Google Scholar
  150. 150.
    Botwinick J, Storandt M. Memory, Related Functions and Age. Springfield, IL: Charles C Thomas, 1974.Google Scholar
  151. 151.
    Tulving E. How many memory systems are there? Am Psychol 1985;40:385–398.Google Scholar
  152. 152.
    Evans DV. Prevalence of Alzheimer’s disease in a community population of older persons. JAMA 1989;262: 2551–2556.PubMedGoogle Scholar
  153. 153.
    Kurtzke JF. Epidemiology of cerebrovascular disease. In: McDowell F, Caplan L (eds) Cerebrovascular Report. Bethesda: NINDS, 1985.Google Scholar
  154. 154.
    McEwen BS. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog Brain Res 1992;93: 365–385.PubMedGoogle Scholar
  155. 155.
    Wooley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990;531: 225–231.Google Scholar
  156. 156.
    Sheline YI, Wang PW, Gado M, Csernansky JG, Vannier MN. Hippocampal atrophy in major depression. Proc Natl Acad Sci USA 1995;93:3908–3913.Google Scholar
  157. 157.
    Bemner JD, Randall R, Scott TM, Bronen R. MRI-based measurement of hippocampal volume in patients with combat-related post-traumatic stress disorder. Am J Psychriatry 1995;152:973–981.Google Scholar
  158. 158.
    Bonica JJ. The Management of Pain, 2nd ed. Philadelphia: Lea & Febiger, 1989.Google Scholar
  159. 159.
    Ferrell BA, Ferrell BR, Osterweil D. Pain in the nursing home. J Am Geriatr Soc 1990;38:409–414.PubMedGoogle Scholar
  160. 160.
    Sengstaken EA, King SA. The problems of pain and its detection among geriatric nursing home residents. J Am Geriatr Soc 1993;41:541–544.PubMedGoogle Scholar
  161. 161.
    Hendler N. The Diagnosis and Nonsurgical Management of Chronic Pain. New York: Raven, 1981.Google Scholar
  162. 162.
    De Vaul R, Hall R, Faillace L. Drug use by the polysurgical patient. Am J Psychiatry 1978;135:682–685.Google Scholar
  163. 163.
    Fry PS, Wong PTP. Pain management training in the elderly: matching interventions with subjects coping styles. Stress Med 1991;7:93–98.Google Scholar
  164. 164.
    Wall RT. Use of analgesics in the elderly. Clin Pharmacol 1990;6:345–347.Google Scholar
  165. 165.
    Roy R, Thomas M. A survey of chronic pain in the elderly population. Can Fam Physician 1986;32:513–516.PubMedGoogle Scholar
  166. 166.
    McCaffery M, Beebe A. Pain in the elderly: special considerations. In: McCaffery M, Beebe A (eds) Pain: Clinical Manual for Nursing Practice. St. Louis: Mosby, 1989: 308–323.Google Scholar
  167. 167.
    Fordyce WE. Evaluating and managing chronic pain. Geriatrics 1978;33:59–62.PubMedGoogle Scholar
  168. 168.
    Libb JW, Clements CB. Token reinforcement in an exercise program for hospitalized geriatric patients. Percept Mot Skills 1969;28:957–958.PubMedGoogle Scholar
  169. 169.
    Holyrod KA, Penzien DB. Client variables and the behavioral treatment of recurrent tension headache: a meta-analytic review. J Behav Med 1986;9:515–536.Google Scholar
  170. 170.
    Middaugh SJ, Woods E, Kee WG, Harden RN, Peters JR. Biofeedback-assisted relaxation training for the aging chronic pain patient. Biofeedback Self Regul 1991;16:361–377.PubMedGoogle Scholar
  171. 171.
    Jessup BA, Gallegos X. Relaxation and biofeedback. In: Wall PD, Melzack R (eds) Textbook of Pain. Edinburgh: Churchill Livingstone, 1994:1321–1335.Google Scholar
  172. 172.
    Noda HH. An exploratory study of the effects of EMG and temperature biofeedback on rheumatoid arthritis. Diss Abstr Int B 1978;39:3532B.Google Scholar
  173. 173.
    Portenoy RK, Farkash A. Practical management of non-malignant pain in the elderly. Geriatrics 1988;43:29–47.PubMedGoogle Scholar
  174. 174.
    Roche RJ, Forman WB. Pain management for the geriatric patient. Clin Podiatr Med Surg 1994;11:41–53.PubMedGoogle Scholar
  175. 175.
    Sandin KJ. Specialized pain treatment for geriatric patients. Clin J Pain 1993;9:60.Google Scholar
  176. 176.
    Sorkin BA, Rudy TE, Hanlon RB, Turk DC, Steig RL. Chronic pain in old and young patients: differences appear less important than similarities. J Gerontol Psychol Sci 1990;45:64–68.Google Scholar
  177. 177.
    Sorkin BA, Turk DC. Pain management in the elderly. In: Roy R (ed) Chronic Pain in Old Age. Toronto: University of Toronto Press, 1995:56–80.Google Scholar
  178. 178.
    Aronoff GM, Evans WO. The prediction of treatment outcome at a multidisciplinary pain center. Pain 1982; 14: 67–73.PubMedGoogle Scholar
  179. 179.
    Middaugh SJ, Levin RB, Kee WG, Barchiesi FD, Robers JM. Chronic pain: its treatment in geriatric and younger patients. Arch Phys Med Rehabil 1988;69: 1021–1025.PubMedGoogle Scholar
  180. 180.
    Rechschaffen A. The function of sleep: methodological issues. In: Drucker-Colin Skurovich M, Sterman MB (eds) The Functions of Sleep. San Diego: Academic, 1979:1–17.Google Scholar
  181. 181.
    Parineu M. Epidemiology of sleep disorders. In: Roth T, Dement WC (eds) Principles and Practice of Sleep Medicine. Philadelphia: Saunders, 1994:437–452.Google Scholar
  182. 182.
    Poelstra RAM. Relationship between physical, psychological, social and environmental variables and subjective sleep quality. Sleep 1984;7:255–260.PubMedGoogle Scholar
  183. 183.
    Bliwise DL. Sleep in normal aging and dementia. Sleep 1993;16:40–81.PubMedGoogle Scholar
  184. 184.
    Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorder. JAMA 1989;262: 1479–1484.PubMedGoogle Scholar
  185. 185.
    Gerard P, Collins KJ, Dore C, Exton-Smith AN. Subjective characteristics of sleep in the elderly. Age Ageing 1978;7(suppl):55–63.Google Scholar
  186. 186.
    Hohagen F, Grabhoff U, Ellringmann D, et al. The prevalence of insomnia in different age groups and its treatment modalities in general practice. In: Smirne S, Franceschi M, Ferini-Strambi L (eds) Sleep and Ageing. Milan: Masson, 1991:205–215.Google Scholar
  187. 187.
    Phillips B, Berry D, Schmitt F, Patel R, Cook Y. Sleep quality and pulmonary function in the healthy elderly. Chest 1989;95:60–64.PubMedGoogle Scholar
  188. 188.
    Habte-Gabr E, Wallace RB, Colsher PL, Hulbert JR. Sleep patterns in rural elders: demographic, health and psycho-behavioral correlates. J Clin Epidemiol 1991; 44:5–13.Google Scholar
  189. 189.
    Lipowski ZJ. Delirium in the elderly patient. N Engl J Med 1989:320:578–582.PubMedGoogle Scholar
  190. 190.
    Greendyke RM, Kanter DR. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study. J Clin Psychiatry 1986:47: 423–426.PubMedGoogle Scholar
  191. 191.
    Jenike MA. Treatment of rage and violence in elderly patients with propranolol. Geriatrics 1983;38:29–34.PubMedGoogle Scholar
  192. 192.
    Jenike MA. Psychoactive drugs in the elderly: antipsychotics and anxiolytics. Geriatrics 1988;43:53–65.PubMedGoogle Scholar
  193. 193.
    Ehlers CL, Kupfer DJ. Effects of age on delta and REM sleep parameters. Electroencephalogr Clin Neurophysiol 1989;72:118–125.PubMedGoogle Scholar
  194. 194.
    Feinberg I. Changes in sleep cycle patterns with age. J Psychiatr Res 1974;10:283–306.PubMedGoogle Scholar
  195. 195.
    Sarajishvili PM, Geladze T, Bibileishvili SE, Shubladze GN, Toidze O. The electroencephalogram sleep patterns of long-lived males. Soobshch Akad Nauk Gruz SSR 1974;75:693–695.Google Scholar
  196. 196.
    Feinberg I, Koresko RL, Heller N. EEG sleep patterns as a function of normal and pathological aging in man. J Psychiatr Res 1967;5:107–144.PubMedGoogle Scholar
  197. 197.
    Gillin JC, Duncan WC, Murphy DL, et al. Age-related changes in sleep in depressed and normal subjects. Psychiatr Res 1981;4:73–78.Google Scholar
  198. 198.
    Spiegel R. Sleep and Sleeplessness in Advanced Age. New York: SP Medical, 1981.Google Scholar
  199. 199.
    Hayashi Y, Endo S. All-night sleep polygraphic recordings of healthy aged persons: REM and slow wave sleep. Sleep 1982;5:277–283.PubMedGoogle Scholar
  200. 200.
    Kales A, Wilson T, Kales JD, et al. Measurements of all-night sleep in normal elderly persons: effects of aging. J Am Geriatr Soc 1967;15:405–414.PubMedGoogle Scholar
  201. 201.
    Williams RL, Karacan I, Hursch CJ. EEG of Human Sleep: Clinical Applications. New York: Wiley, 1974.Google Scholar
  202. 202.
    Hajak G, Klingelhofer J, Schultz-Varszegi M, Ruther E. Blood circulation and energy metabolism of the brain in healthy sleep. Nervenarzt 1993;64:456–467.PubMedGoogle Scholar
  203. 203.
    Maquet P, Peters J, Aerts J, et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996;383:163–166.PubMedGoogle Scholar
  204. 204.
    Rolls BJ, Phillips PA. Aging and disturbances of thirst and fluid balance. Nutr Rev 1990;48:137–144.PubMedGoogle Scholar
  205. 205.
    Conroy C, Kraus JF. Survival after brain injury: cause of death, length of survival, and prognostic variables in a cohort of brain-injured people. Neuroepidemiology 1988;7:13–22.PubMedGoogle Scholar
  206. 206.
    Hernesniemi J. Outcome following head injuries in the aged. Acta Neurol Scand 1970;46:343–348.Google Scholar
  207. 207.
    Luerssen TG, Klauber MR, Marshall LF. Outcome from head injury related to patient’s age: a longitudinal prospective study of adult and pediatric head injury. J Neurosurg 1988;68:409–416.PubMedGoogle Scholar
  208. 208.
    Bush TL, Miller SR, Criqui MH, Barrett-Connor E. Risk factors for morbidity and mortality in older population: an epidemiological approach. In: Hazzard WR, Andres R, Bierman EL, Blass JP (eds) Principles of Geriatric Medicine and Gerontology, 2nd ed. New York: McGraw-Hill, 1990:125–137.Google Scholar
  209. 209.
    Jane JA, Francel PC. Age and outcome of head injury. In: Narayan RK, Wilberger JE, Povlishock JT (eds) Neurotrauma. New York: McGraw-Hill, 1996:793–804.Google Scholar
  210. 210.
    Alberico AM, Ward JD, Choi S, Marmarou A, Young JF. Outcome after severe head injury. J Neurosurg 1987;67: 648–656.PubMedGoogle Scholar
  211. 211.
    Vollmer DJ, Torner JC, Jane JA. Age and outcome following traumatic coma: why do older patients fare worse? J Neurosurg 1991;75:537–549.Google Scholar
  212. 212.
    Vollmer DG. Prognosis and outcome of severe head injury. In: Cooper PR (ed) Head Injury. Baltimore: Williams & Wilkins, 1993:553–581.Google Scholar
  213. 213.
    Dujovny M, Charbel F, Berman SK, Diaz FG, Malik G, Ausman JI. Geriatric neurosurgery. Surg Neurol 1987;28: 10–16.PubMedGoogle Scholar
  214. 214.
    Pentland B, Jones PA, Roy CW. Head injury in the elderly. Age Ageing 1986;15:193–202.PubMedGoogle Scholar
  215. 215.
    Savino JA, Del Guercio LRM. Preoperative cardiopulmonary evaluation and postsurgical convalescence. In: Calkins E, Ford AB, Katz PR (eds) Practice of Geriatrics, 2nd ed. Philadelphia: Saunders, 1992:578–587.Google Scholar
  216. 216.
    de la Torre JC. Cerebral hypoperfusion, capillary degeneration and development of Alzheimer’s disease. Alzheimer Dis Assoc Dis 2000;14:S72-S81.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • J. C. de la Torre
  • L. A. Fay

There are no affiliations available

Personalised recommendations